ORMP
Price
$2.18
Change
+$0.02 (+0.93%)
Updated
Jul 3 closing price
Capitalization
89.05M
39 days until earnings call
TTNP
Price
$4.40
Change
+$0.05 (+1.15%)
Updated
Jul 3 closing price
Capitalization
5.85M
Interact to see
Advertisement

ORMP vs TTNP

Header iconORMP vs TTNP Comparison
Open Charts ORMP vs TTNPBanner chart's image
Oramed Pharmaceuticals
Price$2.18
Change+$0.02 (+0.93%)
Volume$18.03K
Capitalization89.05M
Titan Pharmaceuticals
Price$4.40
Change+$0.05 (+1.15%)
Volume$18.73K
Capitalization5.85M
ORMP vs TTNP Comparison Chart in %
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. TTNP commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and TTNP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (ORMP: $2.18 vs. TTNP: $4.40)
Brand notoriety: ORMP and TTNP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 25% vs. TTNP: 40%
Market capitalization -- ORMP: $89.05M vs. TTNP: $5.85M
ORMP [@Biotechnology] is valued at $89.05M. TTNP’s [@Biotechnology] market capitalization is $5.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileTTNP’s FA Score has 0 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • TTNP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than TTNP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 3 TA indicator(s) are bullish while TTNP’s TA Score has 5 bullish TA indicator(s).

  • ORMP’s TA Score: 3 bullish, 6 bearish.
  • TTNP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TTNP is a better buy in the short-term than ORMP.

Price Growth

ORMP (@Biotechnology) experienced а +0.46% price change this week, while TTNP (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ORMP is expected to report earnings on Aug 13, 2025.

TTNP is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($89.1M) has a higher market cap than TTNP($5.85M). TTNP YTD gains are higher at: 34.969 vs. ORMP (-9.917). TTNP has higher annual earnings (EBITDA): -4.03M vs. ORMP (-21.53M). ORMP has more cash in the bank: 131M vs. TTNP (1.95M). TTNP has less debt than ORMP: TTNP (0) vs ORMP (301K). ORMP has higher revenues than TTNP: ORMP (2M) vs TTNP (0).
ORMPTTNPORMP / TTNP
Capitalization89.1M5.85M1,522%
EBITDA-21.53M-4.03M535%
Gain YTD-9.91734.969-28%
P/E Ratio20.91N/A-
Revenue2M0-
Total Cash131M1.95M6,735%
Total Debt301K0-
FUNDAMENTALS RATINGS
ORMP vs TTNP: Fundamental Ratings
ORMP
TTNP
OUTLOOK RATING
1..100
651
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9398
PRICE GROWTH RATING
1..100
6256
P/E GROWTH RATING
1..100
5380
SEASONALITY SCORE
1..100
7524

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (58) in the Pharmaceuticals Other industry is somewhat better than the same rating for TTNP (100) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew somewhat faster than TTNP’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as TTNP (100) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew similarly to TTNP’s over the last 12 months.

ORMP's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as TTNP (98) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew similarly to TTNP’s over the last 12 months.

TTNP's Price Growth Rating (56) in the Pharmaceuticals Major industry is in the same range as ORMP (62) in the Pharmaceuticals Other industry. This means that TTNP’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (53) in the Pharmaceuticals Other industry is in the same range as TTNP (80) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew similarly to TTNP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPTTNP
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 8 days ago
83%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZVRA9.740.33
+3.51%
Zevra Therapeutics
STSS5.800.10
+1.75%
Sharps Technology Inc
CRS279.584.53
+1.65%
Carpenter Technology Corp
TNYA0.61N/A
-0.15%
Tenaya Therapeutics
HBM10.83-0.13
-1.19%
Hudbay Minerals

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.93%
BTAI - ORMP
44%
Loosely correlated
N/A
INO - ORMP
44%
Loosely correlated
-37.85%
MBIO - ORMP
44%
Loosely correlated
N/A
VERV - ORMP
44%
Loosely correlated
+0.62%
ZNTL - ORMP
43%
Loosely correlated
N/A
More

TTNP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TTNP has been loosely correlated with INM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TTNP jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TTNP
1D Price
Change %
TTNP100%
+1.15%
INM - TTNP
44%
Loosely correlated
-4.59%
ORMP - TTNP
28%
Poorly correlated
+0.93%
SPHRY - TTNP
27%
Poorly correlated
+8.88%
CDTX - TTNP
27%
Poorly correlated
+1.90%
SER - TTNP
26%
Poorly correlated
-3.26%
More